Salim Syed analyst MIZUHO

Currently out of the existing stock ratings of Salim Syed, 103 are a BUY (73.57%), 37 are a HOLD (26.43%).

Salim Syed

Work Performance Price Targets & Ratings Chart

Analyst Salim Syed works at MIZUHO with a stock forecast success ratio of 58.27% fulfilled within 198.85 days on average.

Salim Syed’s has documented 274 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AMGN, Amgen at 09-May-2024.

Wall Street Analyst Salim Syed

Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for NKTX (NKARTA ) at 11/16/2023. The price target of $9 was fulfilled within 53 days with a profit of $6.64 (281.36%) receiving and performance score of 53.09.

Average potential price target upside

AMGN Amgen ASMB Assembly Biosciences BBIO BridgeBio Pharma BIIB Biogen BMY Bristol-Myers Squibb Company CELG Celgene CYTK Cytokinetics GILD Gilead Sciences NKTX Nkarta  UBX Unity Biotechnology WVE Wave Life Sciences Ltd ATRA Atara Biotherapeutics CHRS Coherus BioSciences CRSP Crispr Therapeutics AG

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

235

$-77.47 (-24.79%)

223

9 days ago

15/20 (75%)

$-77.86 (-24.89%)

388

Sell

300

$-12.47 (-3.99%)

230

15 days ago

17/19 (89.47%)

$-11.29 (-3.63%)

223

Hold

307

$-5.47 (-1.75%)

284

15 days ago

10/10 (100%)

$-4.29 (-1.38%)

79

Buy

328

$15.53 (4.97%)

329

15 days ago

6/9 (66.67%)

$16.71 (5.37%)

68

Buy

355

$42.53 (13.61%)

326

15 days ago

17/19 (89.47%)

$43.71 (14.04%)

439

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Salim Syed is most bullish on?

Potential upside of $46.43 has been obtained for BIIB (BIOGEN)

Which stock is Salim Syed is most reserved on?

Potential downside of -$77.47 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Salim Syed?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?